MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel

MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel

Development of chemoresistance remains a major challenge in treating patients suffering from esophageal squamous cell carcinoma (ESCC), despite treatment advances. MicroRNAs (miRNAs) have been shown to play critical roles in the regulation of ESCC cell chemoresistance. Here, we aimed to investigate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jie Yan, Litong Shi, Shan Lin, Yi Li
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
esophageal squamous cell carcinoma
microrna-624
arrestin domain-containing 3
yes-associated protein
hypoxia-inducible factor-1α
cisplatin
paclitaxel
Biotechnology
TP248.13-248.65
Acceso en línea:https://doaj.org/article/56ca190f963944ff9654cde9dc46b769
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/56ca190f963944ff9654cde9dc46b769

Ejemplares similares